Cargando…

Efficacy and effectiveness of inactivated vaccines against symptomatic COVID-19, severe COVID-19, and COVID-19 clinical outcomes in the general population: a systematic review and meta-analysis

BACKGROUND: Inactivated, whole-virion vaccines have been used extensively in the SARS-CoV-2 pandemic. Its efficacy and effectiveness across regions have not been systematically evaluated. Efficacy refers to how well a vaccine performs in a controlled environment. Effectiveness refers to how well it...

Descripción completa

Detalles Bibliográficos
Autores principales:	Law, Martin, Ho, Sam S.H., Tsang, Gigi K.C., Ho, Clarissa M.Y., Kwan, Christine M., Yan, Vincent Ka Chun, Yiu, Hei Hang Edmund, Lai, Francisco Tsz Tsun, Wong, Ian Chi Kei, Chan, Esther Wai Yin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2023
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10199328/ https://www.ncbi.nlm.nih.gov/pubmed/37360863 http://dx.doi.org/10.1016/j.lanwpc.2023.100788

Ejemplares similares

Evaluation of the INDICAID COVID-19 Rapid Antigen Test in Symptomatic Populations and Asymptomatic Community Testing
por: Chiu, Ricky Y. T., et al.
Publicado: (2021)

Risk of acute liver injury following the mRNA (BNT162b2) and inactivated (CoronaVac) COVID-19 vaccines
por: Wong, Carlos King Ho, et al.
Publicado: (2022)

Booster vaccination with inactivated whole-virus or mRNA vaccines and COVID-19–related deaths among people with multimorbidity: a cohort study
por: Lai, Francisco Tsz Tsun, et al.
Publicado: (2023)

Editorials: Inactivated vaccines protection against COVID-19 symptomatic infections
por: Chen, Yifan
Publicado: (2023)

Risk of carditis after three doses of vaccination with mRNA (BNT162b2) or inactivated (CoronaVac) covid-19 vaccination: a self-controlled cases series and a case–control study
por: Fan, Min, et al.
Publicado: (2023)

The effectiveness and safety of mRNA (BNT162b2) and inactivated (CoronaVac) COVID-19 vaccines among individuals with chronic kidney diseases
por: Cheng, Franco Wing Tak, et al.
Publicado: (2022)

Prognosis of Myocarditis Developing After mRNA COVID-19 Vaccination Compared With Viral Myocarditis
por: Lai, Francisco Tsz Tsun, et al.
Publicado: (2022)

Inactivated COVID-19 vaccines: potential concerns of antibody-dependent enhancement and original antigenic sin
por: Kan, Andy Ka Chun, et al.
Publicado: (2023)

Molnupiravir and nirmatrelvir–ritonavir reduce mortality risk during post-acute COVID-19 phase()
por: Wan, Eric Yuk Fai, et al.
Publicado: (2023)

Multimorbidity and adverse events of special interest associated with Covid-19 vaccines in Hong Kong
por: Lai, Francisco Tsz Tsun, et al.
Publicado: (2022)

Sex-based differences in risk of ischaemic stroke or systemic embolism after BNT162b2 or CoronaVac COVID-19 vaccination in patients with atrial fibrillation: a self-controlled case series and nested case-control study
por: Ye, Xuxiao, et al.
Publicado: (2023)

Association between the risk of seizure and COVID‐19 vaccinations: A self‐controlled case‐series study
por: Wan, Eric Yuk Fai, et al.
Publicado: (2022)

Risk of thyroid dysfunction associated with mRNA and inactivated COVID-19 vaccines: a population-based study of 2.3 million vaccine recipients
por: Wong, Carlos King Ho, et al.
Publicado: (2022)

Efficacy of Vaccine Protection Against COVID-19 Virus Infection in Patients with Chronic Liver Diseases
por: Cheung, Carmen Ka Man, et al.
Publicado: (2023)

Clinical characteristics of asymptomatic and symptomatic patients with mild COVID-19
por: Kim, G.-u., et al.
Publicado: (2020)

Characterization of Unlinked Cases of COVID-19 and Implications for Contact Tracing Measures: Retrospective Analysis of Surveillance Data
por: Chong, Ka Chun, et al.
Publicado: (2021)

Safety of an inactivated, whole-virion COVID-19 vaccine (CoronaVac) in people aged 60 years or older in Hong Kong: a modified self-controlled case series
por: Wan, Eric Yuk Fai, et al.
Publicado: (2022)

Patterns of viral clearance in the natural course of asymptomatic COVID-19: Comparison with symptomatic non-severe COVID-19
por: Uhm, Jae-Sun, et al.
Publicado: (2020)

Two-dose COVID-19 vaccination and possible arthritis flare among patients with rheumatoid arthritis in Hong Kong
por: Li, Xue, et al.
Publicado: (2022)

Myocarditis Following COVID-19 BNT162b2 Vaccination Among Adolescents in Hong Kong
por: Li, Xue, et al.
Publicado: (2022)

Psychological well-being and coping strategies of healthcare students during the prolonged COVID-19 pandemic
por: Chan, Phoebe C.F., et al.
Publicado: (2022)

COVID-19 patient with symptomatic bradycardia
por: Eid, Mustafa Mahmood
Publicado: (2021)

Fluvoxamine for symptomatic outpatients with COVID-19
por: Wu, Peter E., et al.
Publicado: (2022)

Bundled interventions for consumption management and monitoring of personal protective equipment in COVID-19 pandemic in Hong Kong local hospitals
por: Kwan, Wai-Man, et al.
Publicado: (2020)

Impact of COVID-19 on pornography use: Evidence from big data analyses
por: Lau, Way Kwok-Wai, et al.
Publicado: (2021)

Comparing hybrid and regular COVID-19 vaccine-induced immunity against the Omicron epidemic
por: Huang, Lei, et al.
Publicado: (2022)

The epidemiology of COVID-19 cases and the successful containment strategy in Hong Kong–January to May 2020
por: Lam, Ho Yeung, et al.
Publicado: (2020)

mRNA (BNT162b2) and Inactivated (CoronaVac) COVID-19 Vaccination and Risk of Adverse Events and Acute Diabetic Complications in Patients with Type 2 Diabetes Mellitus: A Population-Based Study
por: Wan, Eric Yuk Fai, et al.
Publicado: (2022)

Safety and Immunogenicity of Inactivated Bacillus subtilis Spores as a Heterologous Antibody Booster for COVID-19 Vaccines
por: Sung, Johnny Chun-Chau, et al.
Publicado: (2022)

COVID-19 and Regional Income Inequality in China
por: Shen, Jianfu, et al.
Publicado: (2021)

Effectiveness of molnupiravir vs nirmatrelvir-ritonavir in non-hospitalised and hospitalised patients with COVID-19: a target trial emulation study
por: Wan, Eric Yuk Fai, et al.
Publicado: (2023)

Asymptomatic and Pre-Symptomatic COVID-19 in China
por: Wu, Zunyou, et al.
Publicado: (2020)

Infectivity of asymptomatic versus symptomatic COVID-19
por: Sayampanathan, Andrew A, et al.
Publicado: (2021)

Symptomatic Myocarditis Post COVID-19 Vaccination
por: Patel, Palak, et al.
Publicado: (2022)

Unmasking symptomatic dermatographism in the time of COVID-19
por: Wong, Katelyn H, et al.
Publicado: (2020)

Inactivated SARS-CoV-2 vaccine (BBV152)-induced protection against symptomatic COVID-19
por: Li, Jing-Xin, et al.
Publicado: (2021)

Settings of virus exposure and their implications in the propagation of transmission networks in a COVID-19 outbreak
por: Wong, Ngai Sze, et al.
Publicado: (2020)

‘Caring for the helpers’: factors associated with professional quality of life among Hong Kong nurses during the fifth wave of the COVID-19 pandemic
por: Yeung, Nelson Chun Yiu, et al.
Publicado: (2023)

Association between BNT162b2 and CoronaVac vaccination and risk of CVD and mortality after COVID-19 infection: A population-based cohort study
por: Wan, Eric Yuk Fai, et al.
Publicado: (2023)

Effectiveness of adenovirus type 5 vectored and inactivated COVID-19 vaccines against symptomatic COVID-19, COVID-19 pneumonia, and severe COVID-19 caused by the B.1.617.2 (Delta) variant: Evidence from an outbreak in Yunnan, China, 2021
por: Ma, Chao, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_m2id0dpladk1a822nl4oicnf4e